{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Foncologypodcast.simplecast.com%2Fepisodes%2Fhrr-testing-podcast-na1yfWyd","width":444,"version":"1.0","type":"rich","title":"Homologous Recombination Repair (HRR) Testing and Targeted Therapy in Prostate Cancer","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/814f77b2-8235-4c93-be85-252072471d35/7308-prostate-hrr-testing-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/d6d617d2-99ae-47bd-86d0-5606642636d2\" height=\"200\" width=\"100%\" title=\"Homologous Recombination Repair (HRR) Testing and Targeted Therapy in Prostate Cancer\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Listen to this podcast featuring a multidisciplinary discussion between Colin C. Pritchard, MD, PhD, a pathologist, and Heather H. Cheng, MD, PhD, a medical oncologist, for expert guidance on optimal biomarker testing to guide treatment decisions in advanced prostate cancer."}